AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
IMMUNOTHERAPY WITH LOW-DOSE IL-2 PLUS MELATONIN (MLT) IN THE TREATMENT OF ELDERLY ADVANCED CANCER-PATIENTS
Authors: FUMAGALLI L LISSONI P BARNI S BRIVIO F GIANI L
Citation: L. Fumagalli et al., IMMUNOTHERAPY WITH LOW-DOSE IL-2 PLUS MELATONIN (MLT) IN THE TREATMENT OF ELDERLY ADVANCED CANCER-PATIENTS, Annals of oncology, 9, 1998, pp. 68-68
PHYSIOPATHOLOGY OF IL-12 IN HUMAN SOLID NEOPLASMS - BLOOD-LEVELS OF IL-12 IN EARLY OR ADVANCED CANCER-PATIENTS, AND THEIR VARIATIONS WITH SURGERY AND IMMUNOTHERAPY
Authors: LISSONI P MENGO S MANDALA M MAURI E BRIVIO F ROVELLI F CONFALONIERI G LONGARINI R BONFANTE A FOLLI D MEREGALLI S BARNI S TANCINI G GIANI L
Citation: P. Lissoni et al., PHYSIOPATHOLOGY OF IL-12 IN HUMAN SOLID NEOPLASMS - BLOOD-LEVELS OF IL-12 IN EARLY OR ADVANCED CANCER-PATIENTS, AND THEIR VARIATIONS WITH SURGERY AND IMMUNOTHERAPY, Journal of biological regulators and homeostatic agents, 12(1-2), 1998, pp. 38-41
POSSIBLE BIOLOGICAL INDICATORS OF THE RESPONSE TO RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH ADVANCED NEOPLASMS
Authors: BRACZKOWSKI R ZUBELEWICZ B ROMANOWSKI W LISSONI P BRIVIO F
Citation: R. Braczkowski et al., POSSIBLE BIOLOGICAL INDICATORS OF THE RESPONSE TO RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH ADVANCED NEOPLASMS, Journal of experimental & clinical cancer research, 17(3), 1998, pp. 349-354
PREOPERATIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND INFECTIVE COMPLICATIONS IN COLORECTAL SURGERY
Authors: NESPOLI A BRIVIO F GRAMAZIO P CASTOLID M GARIBOLDI G
Citation: A. Nespoli et al., PREOPERATIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND INFECTIVE COMPLICATIONS IN COLORECTAL SURGERY, British Journal of Surgery, 85(6), 1998, pp. 860-860
ACUTE EFFECTS OF PAMIDRONATE ADMINISTRATION ON SERUM LEVELS OF INTERLEUKIN-6 IN ADVANCED SOLID TUMOR PATIENTS WITH BONE METASTASES AND THEIR POSSIBLE IMPLICATIONS IN THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2
Authors: LISSONI P CAZZANIGA M BARNI S PEREGO MS BRIVIO F FUMAGALLI L TANCINI G
Citation: P. Lissoni et al., ACUTE EFFECTS OF PAMIDRONATE ADMINISTRATION ON SERUM LEVELS OF INTERLEUKIN-6 IN ADVANCED SOLID TUMOR PATIENTS WITH BONE METASTASES AND THEIR POSSIBLE IMPLICATIONS IN THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2, European journal of cancer, 33(2), 1997, pp. 304-306
INTERLEUKIN-12 IN EARLY OR ADVANCED CANCER-PATIENTS
Authors: LISSONI P ROVELLI F PITTALIS S CASATI M PEREGO MS GRASSI MG BRIVIO F FUMAGALLI L
Citation: P. Lissoni et al., INTERLEUKIN-12 IN EARLY OR ADVANCED CANCER-PATIENTS, European journal of cancer, 33(10), 1997, pp. 1703-1705
MELATONIN AS A NEW POSSIBLE ANTIINFLAMMATORY AGENT
Authors: LISSONI P ROVELLI F MEREGALLI S FUMAGALLI L MUSCO F BRIVIO F BRIVIO O ESPOSTI G
Citation: P. Lissoni et al., MELATONIN AS A NEW POSSIBLE ANTIINFLAMMATORY AGENT, Journal of biological regulators and homeostatic agents, 11(4), 1997, pp. 157-159
TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BLOOD-LEVELS IN RELATION TO THE ACTIVITY OF THE PINEAL-GLAND IN CANCER-PATIENTS
Authors: LISSONI P BRIVIO F BARNI S TANCINI G ARDIZZOIA A ROVELLI F GRAMAZIO P ALDERI G ZUBELEWICZ B
Citation: P. Lissoni et al., TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BLOOD-LEVELS IN RELATION TO THE ACTIVITY OF THE PINEAL-GLAND IN CANCER-PATIENTS, Biologicals, 24(3), 1996, pp. 214-214
IS THERE A ROLE FOR MELATONIN IN THE TREATMENT OF NEOPLASTIC CACHEXIA
Authors: LISSONI P PAOLOROSSI F TANCINI G BARNI S ARDIZZOIA A BRIVIO F ZUBELEWICZ B CHATIKHINE V
Citation: P. Lissoni et al., IS THERE A ROLE FOR MELATONIN IN THE TREATMENT OF NEOPLASTIC CACHEXIA, European journal of cancer, 32A(8), 1996, pp. 1340-1343
PREVENTION OF CYTOKINE-INDUCED HYPOTENSION IN CANCER-PATIENTS BY THE PINEAL HORMONE MELATONIN
Authors: LISSONI P PITTALIS S ARDIZZOIA A BRIVIO F BARNI S TANCINI G PELIZZONI F MAESTRONI GJM ZUBELEWICZ B BRACZKOWSKI R
Citation: P. Lissoni et al., PREVENTION OF CYTOKINE-INDUCED HYPOTENSION IN CANCER-PATIENTS BY THE PINEAL HORMONE MELATONIN, Supportive care in cancer, 4(4), 1996, pp. 313-316
ADJUVANT THERAPY WITH THE PINEAL HORMONE MELATONIN IN PATIENTS WITH LYMPH-NODE RELAPSE DUE TO MALIGNANT-MELANOMA
Authors: LISSONI P BRIVIO O BRIVIO F BARNI S TANCINI G CRIPPA D MEREGALLI S
Citation: P. Lissoni et al., ADJUVANT THERAPY WITH THE PINEAL HORMONE MELATONIN IN PATIENTS WITH LYMPH-NODE RELAPSE DUE TO MALIGNANT-MELANOMA, Journal of pineal research, 21(4), 1996, pp. 239-242
CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS
Authors: LISSONI P BRIVIO F PITTALIS S ROVELLI F RESCALDANI R PEREGO MS GRASSI MG BARNI S TANCINI G MAJORCA F FUMAGALLI L
Citation: P. Lissoni et al., CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS, Journal of biological regulators and homeostatic agents, 10(2-3), 1996, pp. 60-62
PREOPERATIVE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY MAY PROLONG THESURVIVAL-TIME IN ADVANCED COLORECTAL-CANCER PATIENTS
Authors: BRIVIO F LISSONI P ALDERI G BARNI S LAVORATO F FUMAGALLI L
Citation: F. Brivio et al., PREOPERATIVE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY MAY PROLONG THESURVIVAL-TIME IN ADVANCED COLORECTAL-CANCER PATIENTS, Oncology, 53(4), 1996, pp. 263-268
A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC SOLID TUMOR PATIENTS
Authors: LISSONI P PAOLOROSSI F TANCINI G ARDIZZOIA A BARNI S BRIVIO F MAESTRONI GJM CHILELLI M
Citation: P. Lissoni et al., A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC SOLID TUMOR PATIENTS, British Journal of Cancer, 74(9), 1996, pp. 1466-1468
EFFICACY AND TOLERABILITY OF CANCER NEUROIMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEAL HORMONE MELATONIN - A PROGRESS REPORT OF 200 PATIENTS WITH ADVANCED SOLID NEOPLASMS
Authors: LISSONI P ARDIZZOIA A BARNI S BRIVIO F TISI E ROVELLI F TANCINI G MAESTRONI G FUMAGALLI L
Citation: P. Lissoni et al., EFFICACY AND TOLERABILITY OF CANCER NEUROIMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEAL HORMONE MELATONIN - A PROGRESS REPORT OF 200 PATIENTS WITH ADVANCED SOLID NEOPLASMS, Oncology Reports, 2(6), 1995, pp. 1063-1068
PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA
Authors: BRIVIO F LISSONI P FUMAGALLI L BRIVIO O LAVORATO F RESCALDANI R CONTI A ROSELLI MG MAESTRONI G BARNI S
Citation: F. Brivio et al., PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA, Oncology Reports, 2(4), 1995, pp. 597-599
RELATION BETWEEN MACROPHAGE AND T-HELPER-2 LYMPHOCYTE FUNCTIONS IN HUMAN NEOPLASMS - NEOPTERIN, INTERLEUKIN-10 AND INTERLEUKIN-6 BLOOD-LEVELS IN EARLY OR ADVANCED SOLID TURNERS
Authors: LISSONI P ROVELLI F TISI E BRIVIO F ARDIZZOIA A BARNI S TANCINI G SAUDELLI M CESANA E VIGANO MG
Citation: P. Lissoni et al., RELATION BETWEEN MACROPHAGE AND T-HELPER-2 LYMPHOCYTE FUNCTIONS IN HUMAN NEOPLASMS - NEOPTERIN, INTERLEUKIN-10 AND INTERLEUKIN-6 BLOOD-LEVELS IN EARLY OR ADVANCED SOLID TURNERS, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 146-149
NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN AIDS PATIENTS WITH CD4 CELL NUMBER BELOW 200 MM(3) - A BIOLOGICAL PHASE-II STUDY/
Authors: LISSONI P VIGORE L RESCALDANI R ROVELLI F BRIVIO F GIANI L BARNI S TANCINI G ARDIZZOIA A VIGANO MG
Citation: P. Lissoni et al., NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN AIDS PATIENTS WITH CD4 CELL NUMBER BELOW 200 MM(3) - A BIOLOGICAL PHASE-II STUDY/, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 155-158
TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA BY LOW-DOSE SUBCUTANEOUSINTERLEUKIN-2 PLUS THE PINEAL HORMONE MELATONIN - A BIOLOGICAL PHASE-II STUDY
Authors: LISSONI P BARNI S BRIVIO F ROSSINI F FUMAGALLI L TANCINI G
Citation: P. Lissoni et al., TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA BY LOW-DOSE SUBCUTANEOUSINTERLEUKIN-2 PLUS THE PINEAL HORMONE MELATONIN - A BIOLOGICAL PHASE-II STUDY, Journal of biological regulators and homeostatic agents, 9(2), 1995, pp. 52-54
INTERLEUKIN-2, MELATONIN AND INTERLEUKIN-12 AS A POSSIBLE NEUROIMMUNECOMBINATION IN THE BIOTHERAPY OF CANCER
Authors: LISSONI P PITTALIS S ROVELLI F VIGORE L ROSELLI MG BRIVIO F
Citation: P. Lissoni et al., INTERLEUKIN-2, MELATONIN AND INTERLEUKIN-12 AS A POSSIBLE NEUROIMMUNECOMBINATION IN THE BIOTHERAPY OF CANCER, Journal of biological regulators and homeostatic agents, 9(2), 1995, pp. 63-66
IMMUNE EFFECTS OF PREOPERATIVE IMMUNOTHERAPY WITH HIGH-DOSE SUBCUTANEOUS INTERLEUKIN-2 VERSUS NEUROIMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN GASTROINTESTINAL-TRACT TUMOR PATIENTS
Authors: LISSONI P BRIVIO F BRIVIO O FUMAGALLI L GRAMAZIO F ROSSI M EMANUELLI G ALDERI G LAVORATO F
Citation: P. Lissoni et al., IMMUNE EFFECTS OF PREOPERATIVE IMMUNOTHERAPY WITH HIGH-DOSE SUBCUTANEOUS INTERLEUKIN-2 VERSUS NEUROIMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN GASTROINTESTINAL-TRACT TUMOR PATIENTS, Journal of biological regulators and homeostatic agents, 9(1), 1995, pp. 31-33
PREDICTION OF RECURRENCE IN OPERABLE BREAST-CANCER BY POSTOPERATIVE CHANGES IN PROLACTIN SECRETION
Authors: LISSONI P BARNI S CAZZANIGA M ARDIZZOIA A ROVELLI F TANCINI G BRIVIO F FRIGERIO F
Citation: P. Lissoni et al., PREDICTION OF RECURRENCE IN OPERABLE BREAST-CANCER BY POSTOPERATIVE CHANGES IN PROLACTIN SECRETION, Oncology, 52(6), 1995, pp. 439-442
A BIOLOGICAL STUDY ON THE EFFICACY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN THE TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA
Authors: LISSONI P BARNI S BRIVIO F ROSSINI F FUMAGALLI L ARDIZZOIA A TANCINI G
Citation: P. Lissoni et al., A BIOLOGICAL STUDY ON THE EFFICACY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN THE TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA, Oncology, 52(5), 1995, pp. 360-362
A RANDOMIZED STUDY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VERSUS SUPPORTIVE CARE ALONE IN METASTATIC COLORECTAL-CANCER PATIENTS PROGRESSING UNDER 5-FLUOROURACIL AND FOLATES
Authors: BARNI S LISSONI P CAZZANIGA M ARDIZZOIA A MEREGALLI S FOSSATI V FUMAGALLI L BRIVIO F TANCINI G
Citation: S. Barni et al., A RANDOMIZED STUDY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VERSUS SUPPORTIVE CARE ALONE IN METASTATIC COLORECTAL-CANCER PATIENTS PROGRESSING UNDER 5-FLUOROURACIL AND FOLATES, Oncology, 52(3), 1995, pp. 243-245
A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA
Authors: LISSONI P ARDIZZOIA A MEREGALLI S BARNI S FOSSATI V BRIVIO F TANCINI G
Citation: P. Lissoni et al., A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA, Oncology Reports, 1(6), 1994, pp. 1277-1280
Risultati: 1-25 | 26-36